Search

Your search keyword '"Smirnov LD"' showing total 97 results

Search Constraints

Start Over You searched for: Author "Smirnov LD" Remove constraint Author: "Smirnov LD"
97 results on '"Smirnov LD"'

Search Results

3. Effect of 3-hydroxypyridine derivatives on the central nervous system

4. Inhibition of platelet aggregation by antioxidants

5. Antioxidants as stabilizers of the Ca++ transport enzyme system in sarcoplasmic reticulum membranesin vivo

6. Effect of 3-hydroxypyridines on cyclic nucleotide levels and inhibition of platelet aggregation in man

7. [Antiradical and NO-inhibiting activities of bet-hydroxy(ethoxy) derivatives of nitrous heterocycles].

8. Studying the photoprotective activity of a new class of heteroaromatic antioxidants.

9. [Mexidol effects in extreme conditions (experiments with animals)].

10. [Angioprotective activity of mexicor in atherosclerosis obliterans of the lower limbs].

11. [Relationship of tumor necrosis factor alpha expression with activation of sphingomyelinase and lipid peroxidation after removal of cholestatic factor].

12. [Antistressor and analgesic effects of mexidol, diazepam, paracetamol, and their combinations].

13. [Lipid reducing and antioxidant action of mexicor in patients with diabetes mellitus type 2].

14. [Investigation of the anti-motion sickness effect of 3-hydroxypyridine derivatives].

15. [Interaction of nonelectrolytes, the derivatives of 5-hydroxybenzimidazole, with erythrocyte membrane].

16. [Possible pharmacological correction of metabolic impairments experimental diabetes mellitus by antioxidant].

17. [Effect of hydroxymethylethylpyridine succinate on the cardiac electrophysiological and hemodynamic parameters during experimental thoracotomy and acute myocardial ischemia].

18. [Correction by 2-ethyl-6-methyl-3-hydroxypyridine succinate of the hepatotoxyc, caused at rats introduction tuberculostatics].

19. [Combined administration of mexidol and anti-arrhythmia agents].

20. [Correction of physical performance of mice with the derivatives of 3-oxypyridine and pyridine].

21. [The anti-ischemic effects of 3-hydroxypyridine derivatives in cerebrovascular pathology].

22. [Effect of mexidol and its structural components on carbohydrate level and lipid peroxidation in acute stress].

23. [Is trimetazidine an antioxidant?].

24. [Structural-functional changes in biomembranes during complications of diabetes mellitus and their pharmacological correction].

25. [The bioavailability of tableted drug forms of the new Russian nootropic preparation nooglutil in rabbits].

26. [The hormone-metabolic changes in the diabetic angiopathy].

27. [The effect of 3-hydroxypyridine derivatives on postischemic disorders in the autoregulatory reactions of the cerebral vessels].

29. [The mutagenic and modifying properties of emoxipin studied by micronucleus assay in liver cells].

30. [Synthetic antioxidant correction for disorders of the regulatory and microcirculatory systems in the early stages of experimental atherosclerosis].

31. [The effect of mexidol on the development of experimental peroxide athero-arteriosclerosis].

32. [Antioxidant probucol prevents development of alloxan diabetes and decrease of antioxidant enzyme activity in rat tissues].

33. [Antiradical activity of complex copper compounds (II) on coumarin ligand base].

34. [Effects of antioxidant emoxipin on lipid metabolism in the lungs during development of pulmonary edema].

35. [The antiradical activity of coumarin reductones].

36. [The possible participation of brain peptidases in regulating the memory function during aging].

37. [A new substance with nootropic activity--N-5(hydroxynicotinoyl)-L-glutamic acid].

38. [Effects of a membrane modulator derived from 3-hydroxypyridine class on the development of pulmonary edema].

39. [Effect of inhibitor-antioxidant of 3-hydroxypyridine series on cellular immunity].

40. [Current trends in the search for membrane-active compounds and membrane-active compound-based drugs].

41. [Role of the GABA- and cholinergic systems in the formation of a dissociated state to an antioxidant of the 3-hydroxypyridine class].

42. [Effect of 3-hydroxypyridine derivatives on the central nervous system].

44. [Interaction with cytochrome P-450 as one of the mechanisms of protective action of 3-hydroxypyridines in the diethylnitrosamine poisoning of animals].

45. [Effect of antioxidants on the synthesis of prostaglandins, prostacyclin and thromboxane in different layers of the kidneys of old rats].

47. [Effect of age on the kinetics of the development of spontaneous and transplantable tumors and on chemotherapy effectiveness].

48. [Changes in the cyclic nucleotide level and the inhibition of human thrombocyte aggregation in 3-hydroxypyridine exposure].

49. [3-Hydroxypyridine derivatives--a new class of psychotropic compounds].

50. [Effect of different substances on the x-ray chemiluminescence of solutions of serum albumin and glycyltryptophan].

Catalog

Books, media, physical & digital resources